Search results for: 'disease border'

The Asia‑Pacific (APAC) cross‑border payments and remittance landscape is being reshaped by rapid digital adoption and growing geopolitical complexity, disrupting traditional remittance models and accelerating the shift toward real‑time, interoperable payment ecosystems. A key industry trend is the accelerated migration from cash‑based and informal...

Management of infectious diseases remains a critical challenge for public health professionals who face increasing demand to control the spread of existing and novel diseases. To provide appropriate healthcare assistance, it is imperative to diagnose the exact form of infection from an array of complicated symptoms expressed by the host. As the out...

The current research study discusses the available countermeasures and forthcoming allergic and infectious diseases. The most common allergic diseases such as allergic rhinitis, also know as Hay fever or seasonal allergies; sinusitis; asthma and chronic obstructive pulmonary disease (COPD); atopic dermatitis (or eczema); urticaria (or hives) and mo...

This study will benefit those who are interested in learning about the global border and maritime security market and potential opportunities in this segment. The threat dynamics to national security are evolving, and technology, in turn, will act as a force multiplier for nations to foil illegal attempts to penetrate their sovereign borders. Eac...

The research service primarily encompasses comprehensive analyses of key emerging therapies across AD and PD.The service includes treatment overviews, emerging therapeutic platforms, IP and funding analysis, and emerging innovation profiles across Alzheimer's and Parkinson's diseases. Furthermore, the research service features the impact of key t...

Respiratory diseases are on the rise globally due to various factors, including environmental ones. Obstructive lung diseases such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis are a huge burden on the global healthcare system. Existing therapies can only reduce the impact and provide short-term relief, but are not ca...

Electroceuticals is a rapidly growing field that is pursuing new and innovative solutions to overcome challenges in treating various pain and neurological disorders. Emerging technologies in these areas attract significant interest because of their potential to revolutionize the field, creating promising opportunities for technology developers in t...

This study presents an overview of the Asia-Pacific infectious disease point-of-care testing (POCT) market with an emphasis on some of the key trends and growth opportunities that are shaping the market. The study highlights some of the emerging business models supporting the development and adoption of innovative diagnostic tests. The Asia-Pacif...

The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...